Nacuity Pharmaceuticals Announces Positive Data from Clinical Trial Evaluating NPI-001 to Treat Retinitis Pigmentosa Associated with Usher Syndrome
September 11, 2025 09:00 ET Â | Source: Nacuity Pharmaceuticals, Inc. NPI-001 shows…
Justice4Heroes Campaign Demands Equality in Military Hearing Loss Compensation
Monday 21 July, 2025 PRESS RELEASE FOR IMMEDIATE RELEASE Justice4Heroes Campaign Demands…
